AMT-130

· UniQure Biopharma B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMT-130, covering 2025-03-10 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease [Phase 1, Phase 2]

See pricing